Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Meidahl Petersen, P."'
Autor:
Marie Øbro Fosbøl, Niklas Rye Jørgensen, Peter Meidahl Petersen, Andreas Kjaer, Jann Mortensen
Publikováno v:
EJNMMI Research, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Background The alpha-emitting radionuclide therapy [223Ra]RaCl2 (Radium-223) improves overall survival (OS) and time to symptomatic skeletal event (SSE) in patients with metastatic castration-resistant prostate cancer (mCRPC). Evidence sugge
Externí odkaz:
https://doaj.org/article/27fd0868fcee40fa86e85f622eb1c09b
Autor:
Magdalena Gongora, Johan Stranne, Eva Johansson, Matteo Bottai, Camilla Thellenberg Karlsson, Klaus Brasso, Steinbjørn Hansen, Henrik Jakobsen, Fredrik Jäderling, Henriette Lindberg, Wolfgang Lilleby, Peter Meidahl Petersen, Tuomas Mirtti, Mats Olsson, Antti Rannikko, Martin Andreas Røder, Per Henrik Vincent, Olof Akre
Publikováno v:
European Urology Open Science, Vol 41, Iss , Pp 63-73 (2022)
Background: There is no high-grade evidence for surgery as primary treatment for locally advanced prostate cancer. The SPCG-15 study is the first randomized trial comparing surgical treatment with radiotherapy. Objective: To describe the baseline cha
Externí odkaz:
https://doaj.org/article/b04cc9d0d82d4c2d95a7b3349bafc4a7
Publikováno v:
Physics and Imaging in Radiation Oncology, Vol 22, Iss , Pp 137-141 (2022)
Background and purpose: Radiotherapy (RT) is an important part in the treatment of gastric lymphomas and the prognosis after radiotherapy is very good with a good chance of long-term survival, so prevention of long-term adverse effects is important.
Externí odkaz:
https://doaj.org/article/a1525fdbf5ea4d1bbe28a69a7062874d
Autor:
Maria Elisabeth Lendorf, Peter Meidahl Petersen, Andrea Steen Svendsen, Henriette Lindberg, Klaus Brasso
Publikováno v:
European Urology Open Science, Vol 24, Iss , Pp 25-33 (2021)
Background: Addition of docetaxel to androgen deprivation therapy (ADT) for the treatment of metastatic hormone-sensitive prostate cancer (mHSPC) has been proved to be effective with an overall survival (OS) benefit in phase III clinical trials. The
Externí odkaz:
https://doaj.org/article/a618105dd97a4437a63f2b1c4bc003b7
Autor:
Lotte S. Fog, Vibeke N. Hansen, Flemming Kjær-Kristoffersen, Tim Egholm Berlon, Peter Meidahl Petersen, Henry Mandeville, Lena Specht
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 10, Iss , Pp 1-7 (2019)
Introduction: Total body irradiation (TBI) is a part of the conditioning regimen for bone marrow transplant.At the Royal Marsden (Sutton, UK) and Rigshospitalet (Copenhagen, Denmark), we introduced a step and shoot IMRT (SS IMRT) technique for TBI. T
Externí odkaz:
https://doaj.org/article/43ee068467074d7692f7fb4b44fb883c
Autor:
Marie Øbro Fosbøl, Jann Mortensen, Peter Meidahl Petersen, Annika Loft, Jacob Madsen, Andreas Kjaer
Publikováno v:
Diagnostics, Vol 11, Iss 6, p 1087 (2021)
The aim of this Phase II study was to investigate the potential for response assessment and prognostication of positron emission tomography (PET) using the ligand 68Ga-NOTA-AE105 targeting the urokinase-type plasminogen activator receptor (uPAR) in p
Externí odkaz:
https://doaj.org/article/e22b4865fa1b4f178f1d89e163f341c7
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Sanne Tofte Rasmussen, Jon Trærup Andersen, Torben Kjær Nielsen, Vanja Cejvanovic, Kasper Meidahl Petersen, Trine Henriksen, Allan Weimann, Jens Lykkesfeldt, Henrik Enghusen Poulsen
Publikováno v:
Redox Biology, Vol 9, Iss C, Pp 32-38 (2016)
Simvastatin reduces the blood concentration of cholesterol by inhibiting hydroxymethylglutaryl-coenzyme A reductase, the rate-limiting enzyme in cholesterol synthesis, and thereby reduces the risk of cardiovascular disease. In addition, simvastatin t
Externí odkaz:
https://doaj.org/article/63061fb5997b4904b846c6aade416065
Publikováno v:
Case Reports in Oncology, Vol 5, Iss 2, Pp 444-448 (2012)
We report 3 cases of patients with testicular cancer and stage II seminoma who developed neurological symptoms with bilateral leg weakness about 4 to 9 months after radiation therapy (RT). They all received RT to the para-aortic lymph nodes with a to
Externí odkaz:
https://doaj.org/article/5c7600dcddba4fb69e4b2968342367f9
Autor:
Parker, C., Clarke, N., Cook, A., Kynaston, H., Meidahl Petersen, P., Cross, W., Persad, R., Catton, C., Logue, J., Payne, H.A., Saad, F., Brasso, K., Heath, C., Lindberg, H., Raman, R., Røder, M.A., Zarkar, A., Parulekar, W.R., Parmar, M.K., Sydes, M.R.
Publikováno v:
In Annals of Oncology October 2023 34 Supplement 2:S953-S953